Make a difference! That's what drives us. Our goal? To improve medical care across the spectrum of neurodegenerative diseases.

That is why we put our heart and soul and our expertise from more than 20 years of university clinical experience into the development of innovative software solutions based on neural networks. They add a decisive factor - objective measurability - to existing radiological reporting.

Approximately 64.8 million people worldwide are currently affected by dementia. That's why dementia is the second most feared disease in society after cancer. This makes it all the more important to develop quantitative software solutions that enable early detection of dementia and other neurodegenerative diseases, including Alzheimer's, Parkinson's and multiple sclerosis. For better medicine in the future, for the benefit of the patient.

AIRAscore software solutions enable standardized and objective findings based on exact measurement values. Thus, deviations can be detected at a stage where conventional visual examinations cannot provide reliable results. Based on objective measurement parameters of the brain, the attending physician is able to recognize certain clinical pictures much earlier, to initiate appropriate therapies in time and to monitor individual therapy successes during the course of treatment.

The name AIRAmed stands for precision, innovation, the latest scientific knowledge and above-average service awareness. As a young company, we still have a lot of room for manoeuvre and contribute our passion every day to achieve MORE together.


Software

AI/ML

Health Care

AIRAmed GmbH

AIRAmed GmbH's headquarters in Tübingen, Germany

Description

People (2)

Christiane Lindig

Nicole Dechert-Bausch

Jobs